Short Wave cover image

COVID And Aduhelm On The Agenda At Denver Alzheimer's Meeting

Short Wave

00:00

Cognitive Health Post-COVID and Aduhelm Controversy

This chapter explores the lasting cognitive effects of COVID-19 and introduces Aduhelm, a controversial Alzheimer's drug facing scrutiny over its approval and safety. Experts discuss the ethical implications of its use, potential side effects, and the importance of rigorous patient evaluations before treatment.

Play episode from 06:06
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app